Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

Deepcell Collaborates with the University of Zurich to Deepen the Understanding of Cancer Biology


Deepcell, a life science company pioneering AI-powered cell classification and isolation for basic and translational research, today announced a collaboration with the Levesque Lab at the University of Zurich. The goals of the collaboration are to use Deepcell's technology to identify and sort rare melanoma cells, profile melanoma tissues to gain a deeper understanding about tumor microenvironment, and enable molecular analyses of the sorted cells.

This collaboration brings together one of the leading scientific research institutions in Europe and one of the most innovative life science companies. Deepcell's AI-powered platform analyzes, classifies and isolates viable cells in a label-free manner based on morphology alone. Through its deep learning-based algorithms and unique cell sorting approach, Deepcell supports a quantitative and mechanistic understanding of cell biology.

"Melanoma cells are difficult to isolate with conventional sorting methods because they lack reliable cell surface markers. By isolating and sorting cells using morphology, we may deepen our understanding of the biology of melanoma progression and, in particular, of cell phenotypes and molecular features of cancerous cells," said Dr Levesque, Associate Professor at the University of Zurich.

The Deepcell platform combines high-resolution imaging of cells in flow with real-time cell classification and sorting, using cell morphology as the only analyte. This label-free, target-agnostic approach overcomes some of the limitations of cell surface marker-based classification and enrichment, including the limited number of available markers and channels for detection, prior knowledge or guesswork required to select surface proteins, and availability of protein-specific antibodies. Importantly, the technology not only analyzes the cellular phenotype, but also enables the isolation of viable, unperturbed cells, allowing for the linkage of cell morphology with molecular data and functional assays.

"We continue to expand our collaborations with world-class researchers, such as teaming up with Dr Levesque and his team at the University of Zurich," said Maddison Masaeli, Co-founder and CEO of Deepcell. "Our unique AI-powered technology transforms cell morphology into a precise, reproducible and unbiased analyte that enables highly accurate cell classification while maintaining cell viability. With the researchers at the University of Zurich, we will be able to generate rich data to help elucidate the complex tumor microenvironment."

For more information about Deepcell, go to www.deepcell.com.

About Deepcell

Deepcell is helping to advance precision medicine by combining advances in AI, cell classification and capture, and single-cell analysis to deliver novel insights through an unprecedented view of cell biology. Spun out of Stanford University in 2017, the company has created unique, microfluidics-based technology that uses continuously learning AI to classify cells based on detailed visual features and sort them without inherent bias. The Deepcell platform maintains cell viability for downstream single-cell analysis and can be used to isolate virtually any type of cell, even those occurring at frequencies as low as one in a billion. The technology will initially be available as a service for use in translational research as well as diagnostics and therapeutic development. Deepcell is privately held and based in Menlo Park, CA. For more information, please visit deepcellbio.com.


These press releases may also interest you

at 17:30
With shopping season, it's peak time for scammers and hackers to wreak havoc on unsuspecting shoppers. According to Juniper research, e-commerce fraud will surpass $20B in 2021, an 18% jump over last year. "As alluring as good deals may be, don't be...

at 17:00
Kalkine Pty Limited is pleased to announce the launch of its 'Cryptocurrency Research' to provide insights in the blockchain technology space. The abatement of bond yields across the globe and proliferation of blockchain technology in varied...

at 13:50
Cyber Monday sales researchers have shared the top NordVPN deals for Cyber Monday, featuring offers on annual plans for VPN & password managers. Links to the latest deals are listed below. Best NordVPN Deals: Save up to 72% on NordVPN's VPN plans...

at 13:13
During the forecast period, the Mobile Device Management industry will see an increase in spending of around USD 3.9 billion. However, the majority of this expansion will be driven by only a few regions. Furthermore, due to their supplier base, North...

at 13:05
AMC Theatres , the largest theatrical exhibitor in the United States, in Europe & the Middle East and in the world, today announced that for the first time ever, members of its AMC Stubs Premiere, AMC Stubs A-List and AMC Investor Connect who advance...

at 10:00
South Korean artificial intelligence (AI) developer VUNO Inc. announced that it will join the Radiological Society of North America 2021 (RSNA 2021), one of the biggest annual events, featuring a series of industry symposia in radiology. This year,...



News published on 12 october 2021 at 10:05 and distributed by: